title: Reply: Is a Trial of Vitamin K Antagonists and Bisphosphonates Possible in IPF?
authors.affiliation: 1 Royal Brompton Hospital London, United Kingdom and.
authors.forename: George A
authors.identifier: 0000-0003-1418-8596
authors.initials: GA
authors.lastname: Margaritopoulos
authors.affiliation: 2 University Hospital of Heraklion Heraklion, Greece.
authors.forename: Katerina M
authors.initials: KM
authors.lastname: Antoniou
mesh_terms: D000925:Anticoagulants; D004164:Diphosphonates; D005343:Fibrinolytic Agents; D006801:Humans; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D004164:Diphosphonates; D005343:Fibrinolytic Agents; D014812:Vitamin K